Rahendra Wira Hermawan, Ida Bagus Narmada, Irwadi Djaharu’ddin, Alexander Patera Nugraha, Dwi Rahmawati
Rahendra Wira Hermawan, Ida Bagus Narmada*, Irwadi Djaharu’ddin, Alexander Patera Nugraha, Dwi Rahmawati
Orthodontics Department, Faculty of Dental Medicine, Airlangga University, Surabaya, Indonesia.
Volume - 13,
Issue - 4,
Year - 2020
Orthodontic tooth movement is obtained through alveolar bone remodeling and periodontal tissue in response to the mechanical forces. Epigallocatechin Gallate (EGCG) is the most abundant bioactive component in green tea which is promising therapy for bone remodeling. The aim of the study was to elucidate the effect of EGCG to the expression of Nuclear Factor of Associated T Cells-1 (NFATC1) and sclerostin (SOST) in orthodontic tooth movement animal model. The samples consisted of 28-healthy male wistar rats (Rattus Novergicus) which were randomly selected then divided into 4 groups (n=7): negative control group (K-) without Orthodontic Tooth Movement (OTM) and EGCG; positive control group (K+) with OTM and without EGCG, group (T1) with OTM and EGCG from day 7 to day 14, group (T2) with OTM (14 days) and EGCG for 14 days. The OTM were installed from the labial surfaces of both maxillary central incisor with light force of 10g/mm2 close coil spring connected to the first left maxillary molar. NFATC1 and SOST expression in the alveolar bone was examined by means of Imunohistochemistry. Analysis of Variance (ANOVA) then continued with Tukey HSD (p<0.05) was done. The highest number of NFATc1 and SOST expression was found in the K+ group compression area. There were significant different of NFATc1 and SOST expression in compression and tensile area between groups (p<0.05). Daily oral administration of EGCG for 14 days can reduce the SOST and NFATc1 expression during OTM in compression area and tensile area during OTM.
Cite this article:
Rahendra Wira Hermawan, Ida Bagus Narmada, Irwadi Djaharu’ddin, Alexander Patera Nugraha, Dwi Rahmawati. The Influence of Epigallocatechin Gallate on the Nuclear Factor Associated T Cell-1 and Sclerostin Expression in Wistar Rats (Rattus novergicus) during the Orthodontic Tooth Movement. Research J. Pharm. and Tech. 2020; 13(4):1730-1734. doi: 10.5958/0974-360X.2020.00312.1
1. Krishnan V, Davidovitch Z. Cellular, molecular, and tissue-level reactions to orthodontic force. Am J Orthod Dentofac Orthop 2006; 129(4):1-32.
2. Narmada IB, Rubianto M, Putra ST. The Role of Low-Intensity Biostimulation Laser Therapy in Transforming Growth Factor β1, Bone Alkaline Phosphatase and Osteocalcin Expression during Orthodontic Tooth Movement in Cavia porcellus. Eur J Dent 2019;13:102–107.
3. Narmada IB, Husodo KRD, Ardani IGA, Rahmawati D, Nugraha AP, Iskandar RPD. Effect of Vitamin D during Orthodontic Tooth Movement on Receptor Activator of Nuclear Factor Kappa-Β Ligand Expression and Osteoclast Number in Pregnant Wistar Rat (Rattus novergicus). J Krishna Instit Med Sci Univ 2019;8(1):37-42.
4. Kumar MPS, Nandhini T. Mechanism of action of Bone Morphogenic Protein 3 in the maintenance of Tissue Homeostasis. Research J. Pharm. and Tech 2018; 11(3): 1270-1274.
5. Nugraha AP, Narmada IB, Ernawati DS, Dinaryanti A, Hendrianto E, Riawan W, Rantam FA: Bone alkaline phosphatase and osteocalcin expression of rat’s Gingival mesenchymal stem cells cultured in plateletrich fibrin for bone remodeling (in vitro study). Eur J Dent 2018; 12 (4): 566-573.
6. Kumar MPS, Devishree. Role of Bone Morphogenic Protein 3 in the regulation of Bone Growth and Development. Research J. Pharm. and Tech. 2018; 11(3): 1251-1254.
7. Suman VB, Chattterjee PK, Vinodini NA, Kunal K, Gokul M, Bhat RM. Effect of variable Diet and Physical Activity on Bone Mineral Density in Adults using Peripheral–Dexa Scan. Research J. Pharm. and Tech 2018; 11(6): 2404-2407.
8. Weivoda MM, Youssef SJ, Oursler MJ. Sclerostin expression and functions beyond the osteocyte. Bone. 2017;96:45–50.
9. MacDonald BT, He X. Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect Biol. 2012; 4(12): a007880. Published 2012 Dec 1
10. Wergedal JE, Veskovic K, Hellan M, Nyght C, Balemans W, Libanati C, et al. Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal. The Journal of clinical endocrinology and metabolism 2003; 88(12):5778–83.
11. Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM, Atkins GJ. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PloS one. 2011; 6(10):e25900.
12. Shu R, Bai D, Sheu T, et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. PLoS One. 2017;12(1):e0167312.
13. Moustafa A, Sugiyama T, Prasad J, Zaman G, Gross TS, Lanyon LE, et al. Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012; 23(4):1225–34.
14. Liu F, Chen C, Lee C, Wu C, Hsu T, Tsai CY, Huang HS, Chang DM. The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation. Int. J. Med. Sci. 2017; 14(9): 840-852.
15. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139–146.
16. Pramila K, Julius A. Antihyperglycemic, Antidyslipidemic and Antifibrotic effect of EGCG in STZ - High Fat Diet Induced DCM rats. Research J. Pharm. and Tech. 2019; 12(4): 1839-1842.
17. Amurdhavani BS. Benefits of Green Tea in Dentistry-A Review. Research J. Pharm. and Tech 2015;8(6): 772-774.
18. Pramila K, Julius A. In Vitro Antioxidant effect of Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) in Protecting Cardiovascular Diseases. Research J. Pharm. and Tech. 2019; 12(3): 1265-1267.
19. Shen CL, Cao JJ, Dagda RY, James K, Wang JS. Green Tea and Bone Metabolism. 2009. Nutr Res; 29(7): 437-456.
20. Kiran S Avadhani, Muthukumar Amirthalingam, Meka Sreenivasa Reddy, Nayanabhirama Udupa, Srinivas Mutalik. Development and Validation of RP-HPLC Method for Estimation of Epigallocatechin -3-gallate (EGCG) in Lipid based Nanoformulations. Research J. Pharm. and Tech. 2016; 9(6):725-730.
21. Rahayu RP, Prasetyo RA, Purwanto DA, Kresnoadi U, Iskandar RPD, Rubianto M. The immunomodulatory effect of green tea (Camellia sinensis) leaves extract on immunocompromised Wistar rats infected by Candida albicans. Vet World 2018;11(6):765–770.
22. Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab. 2014;21(4):233–241. doi:10.11005/jbm.2014.21.4.233
23. Strukov VI, Kislov AI, Eremina NV, Deriabina GP, Yu M, Kondrachenko S, Yu A. Antropov A, et al. The use of Bone Tissue Non-Steroid Anabolizators in Treatment of Osteoporosis. Research J. Pharm. and Tech. 2019; 12(5):2195-2199.
24. Chen ST, Kang L, Wang CZ, et al. (-)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin. Molecules. 2019;24(1):156.
25. Austermann K, Baecker N, Stehle P, Heer M. Putative Effects of Nutritive Polyphenols on Bone Metabolism In Vivo-Evidence from Human Studies. Nutrients. 2019;11(4): E871.
26. Ohta T. Kozawa O. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. J. Cell Biochem. 2007;100:1146–1153.
27. Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH. Inhibitory effects of green tea polyphenol (−) epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J. Periodontal. Res. 2004;39:300–307.
28. Morinobu A, Biao W, Tanaka S, Horiuchi M, Jun L, Tsuji G, Sakai Y, Kurosaka M, Kumagai S. (−)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis Rheum. 2008;58:2012–2018.
29. Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol. Pharmacol. 2010;77:17–25
30. Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018;18(1): e8